• SENSEX 75,722.65
    -410.16 (--0.54%)
  • BANKNIFTY 57,088.30
    -281.35 (--0.49%)
  • Meesho
    213.95 254.65(%)
  • ESDS Software
    1,289.55 1,074.65(%)
  • GE Vernova T&D
    4,747.70 5,650.00(%)
  • IFCI
    92.70 46.20(%)
  • MV Electrosystems
    875.35 841.00(%)
  • Hindustan Copper
    537.35 759.20(%)
  • Hind.Aeronautics
    5,060.00 5,149.90(%)
  • Sterlite Tech.
    827.00 787.65(%)
  • PC Jeweller
    13.17 7.45(%)
  • TCS
    2,244.50 1,976.00(%)
  • Nuvoco Vistas
    341.70 276.30(%)
  • Divi's Lab.
    9,488.00 9,305.00(%)
  • Bharat Electron
    415.20 473.25(%)
  • Tube Investments
    2,627.10 2,165.05(%)
  • Data Pattern
    4,919.20 5,000.00(%)
  • Fortis Health.
    903.50 767.30(%)
  • Eicher Motors
    7,654.70 6,439.45(%)
  • Raymond
    856.00 789.00(%)
  • Milky Mist Dairy
    288.10 277.80(%)
  • Solar Industries
    22,469.95 22,188.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Onyx Biotec Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 93585.0
  • ISIN : INE0WVU01018
39.35 2 (4.93%)
  • As on 08 Sep 2026 (EOD)

  • Today’s Low

    37.80

  • Today’s High

    39.35

  • Open

    37.80

  • Perv Close

    37.50

  • 52W Low

    24.20

  • 52W High

    50.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    71.35

  • Div & Yield %

    0.00

  • Book Value(₹)

    30.56

  • Debt-Equity Ratio

    4.93

  • AGM Date

    07-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    71.35

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    18.13

  • BV (₹)

    30.60

  • Sales( ₹ in Cr.)

    69.47

  • NP (in Cr.)

    -0.21

  • NP Var(%)

    -105.0

  • Div%

    0.0

  • CPS (₹)

    1.60

  • EPS (₹)

    -0.10

  • Traded Value (₹ in Lakhs)

    71.35

  • 52 Week High

    50.00

  • 52 Week Low

    24.20

  • Price BSE

    0.0

  • Price NSE

    39.00

  • Market Capital( in Cr.)

    71.35

  • P/C Ratio

    24.90

  • P/E Ratio

    -329.80

  • Price Vs.BV

    -0.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar
INCOME :            
Sales Turnover 61.95 53.75 39.49 44.86 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 61.95 53.75 39.49 44.86 - -
Other Income 1.17 0.13 0.12 0.12 - -
Stock Adjustments -0.53 0.43 0.28 -0.05 - -
Total Income 62.59 54.31 39.89 44.93 - -
EXPENDITURE :            
Raw Materials 38.61 36.17 21.30 26.47 - -
Power and Fuel Cost 0.00 0.00 0.00 0.00 - -
Employee Cost 8.64 5.94 10.48 8.62 - -
Other Manufacturing Expenses 1.29 1.39 1.51 1.84 - -
Selling and Administration Expenses 2.20 2.08 1.76 2.06 - -
Miscellaneous Expenses 0.31 0.20 0.23 0.04 - -
Employee Benefit Expenses 8.64 5.94 10.48 8.62 - -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 - -
Total Expenses 51.06 45.79 35.28 39.04 - -
Operating Profit 11.55 8.52 4.61 5.89 - -
Interest 2.02 2.16 0.57 0.65 - -
Gross Profit 9.53 6.36 4.04 5.24 - -
Depreciation 3.05 1.87 1.49 1.45 - -
Profit Before Tax 6.48 4.49 2.55 3.79 - -
Current Tax 1.06 0.31 0.26 0.65 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax 0.46 0.55 0.44 -0.21 - -
Reported Net Profit 4.95 3.63 1.84 3.35 - -
Extraordinary Items 0.73 0.00 -0.01 0.00 - -
Adjusted Net Profit 4.22 3.63 1.85 3.35 - -
Adjustment below Net Profit 0.00 -5.68 -0.02 0.09 - -
P & L Balance brought forward 9.84 11.89 10.26 6.81 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 14.79 9.84 12.08 10.26 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 2.73 2.73 3.13 5.68 - -
Earnings Per Share(Adj)-Unit Curr 2.73 - - - - -
Book Value 30.68 18.98 30.84 27.75 - -
Book Value(Adj)-Unit Curr 30.68 - - - - -

Shareholding Pattern

  • Promoter Group

    65.10%

  • Public Share Holding

    34.90%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,803,200 65.10 11,803,200 3
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 11,803,200 65.10 11,803,200 3
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 194,000 1.07 194,000 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 434,000 2.39 434,000 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 628,000 3.46 628,000 3
2] Non Institution
Bodies Corporate 1,288,000 7.10 1,288,000 21
Clearing Members 190,000 1.05 190,000 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 22,000 0.12 22,000 6
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,337,500 12.89 2,337,500 38
Individuals holding nominal share capital up to Rs. 1 lakh 1,859,500 10.26 1,859,500 513
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 4,000 0.02 4,000 1
Sub Total 5,701,000 31.44 5,701,000 580
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 18,132,200 100.00 18,132,200 586

Company Background

Onyx Biotec LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Onyx Biotec Ltd
  • BSE Code : 93585.0
  • ISIN : INE0WVU01018

  • Incorporation Year

    2005

  • Registered Office

    Bir Plassi Near Sainimajraropr
    Nalagarh Rd Dist Solan, Solan,
    Himachal Pradesh-174101

  • Telephone

    +91 172 265 6384

  • FAX

  • Chairman

  • Managing Director

  • Company Secretary

    Ruchi Chowdhury

  • Auditor

    R C A & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Mas Services Limited
    T-34 2nd Floor,
    Okhla Industrial Are,Phase II
    Mumbai - New Delhi - 110020

Onyx Biotec Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Onyx Biotec 39.35 63.12 61.95 -327.92 12.15
Abbott India 25,896.45 7,217.19 6,929.05 34.08 43.78
Astrazeneca Phar 6,853.70 2,304.07 2,275.58 101.01 27.86
Glaxosmi. Pharma 2,956.95 3,932.76 3,790.20 47.24 58.17
Novartis India 1,639.90 393.10 354.33 41.41 15.94
Cipla 1,395.95 20,102.60 18,979.95 36.69 13.88
Bliss GVS Pharma 696.45 773.53 729.81 64.73 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 496.40 474.15 450.25 23.17 18.77
Guj. Themis Bio. 429.65 152.47 150.80 114.88 27.21
Ambalal Sarabhai 42.42 19.52 3.94 78.56 6.77